Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025)
Siga Technologies' (SIGA) quarterly Change in Accured Expenses came in at $6.3 million in Q3 2025, up 728.17% on a YoY basis from $766720.0 in Q3 2024, and up 165.89% quarter-over-quarter from -$9.6 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Change in Accured Expenses for 16 consecutive years, with $6.3 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Change in Accured Expenses rose 728.17% year-over-year to $6.3 million; the trailing twelve-month figure through Sep 2025 stood at $5.0 million (up 346.95% YoY), and the FY2024 full-year result was -$5.7 million, down 387.43% from the prior year.
- Change in Accured Expenses climbed to $6.3 million in Q3 2025 per SIGA's latest filing, from -$9.6 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $11.0 million in Q3 2021 and bottomed at -$9.6 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $336053.5 across 5 years, with a median of $619665.0 in 2022.
- The widest YoY moves for Change in Accured Expenses: up 728.17% in 2025, down 906.11% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$7.6 million in 2021, then soared by 108.13% to $619665.0 in 2022, then soared by 161.02% to $1.6 million in 2023, then sank by 228.58% to -$2.1 million in 2024, then surged by 405.32% to $6.3 million in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $6.3 million, -$9.6 million, and $10.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 2.32 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 55.78 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | -204.33 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | -4.00 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 766,720.00 |
| Jun 30, 2024 | -957,798.00 |
| Mar 31, 2024 | -3.47 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | -3.07 Mn |
| Dec 31, 2022 | 619,665.00 |
| Sep 30, 2022 | -668,540.00 |
| Jun 30, 2022 | 3.46 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -7.62 Mn |
| Sep 30, 2021 | 11.02 Mn |
| Jun 30, 2021 | 1.40 Mn |
| Mar 31, 2021 | -3.33 Mn |
| Dec 31, 2020 | -3.59 Mn |